Petit, A. M., Rak, J., Hung, M. C., Rockwell, P., Goldstein, N., Fendly, B., & Kerbel, R. S. (1997). Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors.
Chicago ZitierstilPetit, A. M., J. Rak, M. C. Hung, P. Rockwell, N. Goldstein, B. Fendly, und R. S. Kerbel. Neutralizing Antibodies against Epidermal Growth Factor and ErbB-2/neu Receptor Tyrosine Kinases Down-regulate Vascular Endothelial Growth Factor Production By Tumor Cells in Vitro and in Vivo: Angiogenic Implications for Signal Transduction Therapy of Solid Tumors. 1997.
MLA ZitierstilPetit, A. M., et al. Neutralizing Antibodies against Epidermal Growth Factor and ErbB-2/neu Receptor Tyrosine Kinases Down-regulate Vascular Endothelial Growth Factor Production By Tumor Cells in Vitro and in Vivo: Angiogenic Implications for Signal Transduction Therapy of Solid Tumors. 1997.